This activity is supported by an unrestricted educational grant from Bristol-Myers Squibb, Genentech, Inc., and Merck & Co.

Non-Small Cell Lung Cancer: Immunotherapy

Suzanne Walker, CRNP, MSN, AOCN, BC
Abramson Cancer Center at Penn-Presbyterian Medical Center

Immunotherapy has made groundbreaking news across tumor types including an exciting emerging role in NSCLC.  It is imperative for APs to understand this innovative approach in treating NSCLC.  This activity provides an invaluable overview of the immune system, the role of checkpoint inhibitors, unique treatment considerations such as pseudo progression, immune mediated side effect profiles of these newer agents and management.


Download Podcast


Download Transcript


Download Slides


Download Slides & Transcripts


These CE/CME/CEU accredited activities are jointly provided by

JADPRO Logo    Harborside Press Logo    APSHO Logo    Annenberg Logo
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here